Sleep Disorders | Sleep Review
Signifier Medical Technologies Ltd has reached the milestone of 50,000 therapy sessions with its sleep apnea therapy device eXciteOSA.
EXciteOSA is a daytime treatment for snoring and mild obstructive sleep apnea (OSA) and received FDA approval and clearance in February 2021. The device is used for 20 minutes a day for six weeks and then twice a week for maintenance.
“We are excited about what this milestone represents in improving patient care,” said Akhil Tripathi, CEO and co-founder of Signifier Medical Technologies, in a press release. “The comfortable and effective treatment has helped patients adhere to their therapy and feel the difference. 50,000 sessions are just the beginning and we look forward to serving millions of people with mild OSA and snoring. “
Unlike devices used by patients while they sleep, the eXciteOSA is the first device on the market designed for use while awake. It works by applying neuromuscular electrical stimulation to the genioglossus muscle – the main muscle that makes up the tongue mass. Neuromuscular electrical stimulation creates contractions of the tongue muscle, which improves function and endurance, so that after 6 weeks of therapy the tongue remains in an ideal position for optimal airflow.
“EXciteOSA was a lifesaver for me and my family. The device significantly reduced my snoring after only 2 weeks of use, ”said Jessie Cadet-Legros, an eXciteOSA patient, in a press release. “It was easy to find 20 minutes a day to use and the results have paid off. My husband now sleeps better without my snoring and so do I. “